New insights on how the microbiome may dictate the efficacy of chemotherapeutic drugs
19 Jun 2017by Andreu Prados
Previous research has shown that the gut microbiome could influence cancer outcomes through its interaction with host immunity. Indeed, mouse studies have shown the anti-cancer effects of chemotherapeutic drugs such as cyclophosphamide and celecoxib could be mediated by commensal species.